Baird Financial Group’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-245,801
| Closed | -$1.01M | – | 1890 |
|
|
2022
Q1 | $1.01M | Hold |
245,801
| – | – | ﹤0.01% | 1144 |
|
|
2021
Q4 | $878K | Hold |
245,801
| – | – | ﹤0.01% | 1252 |
|
|
2021
Q3 | $895K | Buy |
245,801
+5,000
| +2% | +$20.2K | ﹤0.01% | 1249 |
|
|
2021
Q2 | $1.05M | Buy |
240,801
+37,000
| +18% | +$151K | ﹤0.01% | 1162 |
|
|
2021
Q1 | $838K | Hold |
203,801
| – | – | ﹤0.01% | 1195 |
|
|
2020
Q4 | $813K | Buy |
203,801
+1,000
| +0.5% | +$3.23K | ﹤0.01% | 1081 |
|
|
2020
Q3 | $548K | Buy |
202,801
+4,000
| +2% | +$11.1K | ﹤0.01% | 1128 |
|
|
2020
Q2 | $547K | Hold |
198,801
| – | – | ﹤0.01% | 1123 |
|
|
2020
Q1 | $469K | Buy |
198,801
+27,061
| +16% | +$92K | ﹤0.01% | 1080 |
|
|
2019
Q4 | $807K | Sell |
171,740
-20,061
| -10% | -$82.1K | ﹤0.01% | 1026 |
|
|
2019
Q3 | $642K | Hold |
191,801
| – | – | ﹤0.01% | 1095 |
|
|
2019
Q2 | $631K | Hold |
191,801
| – | – | ﹤0.01% | 1132 |
|
|
2019
Q1 | $581K | Hold |
191,801
| – | – | ﹤0.01% | 990 |
|
|
2018
Q4 | $522K | Buy |
191,801
+14,450
| +8% | +$47.6K | ﹤0.01% | 974 |
|
|
2018
Q3 | $578K | Sell |
177,351
-2,160
| -1% | -$6.67K | ﹤0.01% | 1005 |
|
|
2018
Q2 | $463K | Buy |
179,511
+8,201
| +5% | +$20.4K | ﹤0.01% | 1038 |
|
|
2018
Q1 | $377K | Hold |
171,310
| – | – | ﹤0.01% | 1074 |
|
|
2017
Q4 | $341K | Sell |
171,310
-18,000
| -10% | -$39.2K | ﹤0.01% | 1106 |
|
|
2017
Q3 | $613K | Sell |
189,310
-6,000
| -3% | -$18.5K | ﹤0.01% | 933 |
|
|
2017
Q2 | $629K | Sell |
195,310
-1,700
| -0.9% | -$4.82K | ﹤0.01% | 905 |
|
|
2017
Q1 | $560K | Sell |
197,010
-2,201
| -1% | -$5.29K | ﹤0.01% | 925 |
|
|
2016
Q4 | $464K | Sell |
199,211
-33,333
| -14% | -$63.5K | ﹤0.01% | 937 |
|
|
2016
Q3 | $391K | Sell |
232,544
-17,456
| -7% | -$21.4K | ﹤0.01% | 994 |
|
|
2016
Q2 | $250K | Hold |
250,000
| – | – | ﹤0.01% | 1085 |
|
|
2016
Q1 | $218K | Hold |
250,000
| – | – | ﹤0.01% | 1132 |
|
|
2015
Q4 | $303K | Hold |
250,000
| – | – | ﹤0.01% | 1063 |
|
|
2015
Q3 | $425K | Sell |
250,000
-12,000
| -5% | -$23.5K | ﹤0.01% | 964 |
|
|
2015
Q2 | $545K | Buy |
+262,000
| New | +$635K | 0.01% | 930 |
|
Other funds holding ATRS
Baird Financial Group's ATRS Position: Q2 2022 in Review
Baird Financial Group sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 245,801 shares — an estimated $1.01M sold.
Baird Financial Group first reported a position in ATRS in Q2 2015 and held it in 28 quarters. The position peaked at $1.05M in Q2 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Baird Financial Group reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Baird Financial Group sold 245,801 Antares Pharma, Inc. shares in Q2 2022, an estimated $1.01M.
- Baird Financial Group first reported a position in Antares Pharma, Inc. in Q2 2015 and held it in 28 quarters.
- Baird Financial Group's Antares Pharma, Inc. position peaked at $1.05M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Baird Financial Group's 13F filing for Q2 2022, filed 8 Aug 2022.